查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493333

美国人工电子耳市场规模、份额和趋势分析报告：按年龄层、最终用途、地区和细分市场预测，2024-2030 年

U.S. Cochlear Implants Market Size, Share & Trends Analysis Report By Age Group (Adult, Pediatric), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

美国人工电子耳市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，美国人工电子耳市场规模预计将达到9.401亿美元，2024年至2030年复合年增长率为6.08%。

美国残障人士数量的不断增加以及与老龄化相关的听力损失的普遍存在正在推动美国市场对人工电子耳的需求。

根据美国耳聋和耳聋研究所 (NIDCD) 的数据，美国每 1,000 名儿童中就有 2 到 3 名患有明显的听力损失，据说美国每1,000 名婴儿中约有1 名患有感音神经性听力损失。 2019 年，美国食品药物管理局(FDA) 批准为 5 岁及以上单侧听力损失 (SSD) 儿童植入人工电子耳，以帮助这些患者。

透过提高人们对听力损失和人工电子耳益处的认识，这些组织将增加需求，促进对技术的更好理解，并推动市场成长。政府的措施着重于听力残障人士的治疗价值和歧视问题，例如扩大美国人工电子耳的覆盖范围，将推动市场扩张。

美国人工电子耳市场报告亮点：

  • 按年龄组别划分，由于听力损失盛行率不断上升，2023 年成人占据最大市场占有率，超过 64.2%。预计 2024 年至 2030 年，儿科市场将以最快的复合年增长率成长。
  • 根据最终用途，诊所业务在 2023 年占据最大收益占有率。诊所，特别是耳鼻喉科诊所，是人工电子耳服务的重要提供者，提供评估人工电子耳候选人、进行手术和提供术后护理的专业知识。
  • 诊断率的提高、听力损失意识的提高、双耳佩戴需求的增加以及政府支持计划预计将成为推动这一增长的因素。
  • 2021 年 6 月，奥迪康医疗的 NeuroSystem 获得了美国食品药物管理局(FDA) 的上市前核准(PMA)，该产品适用于 18 岁及以上患有双侧重度至极重度感觉神经性听力损失。当穿戴式科技透过人工电子耳产品进入美国市场时，这些人将从中获得的好处有限。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国人工电子耳市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国人工电子耳市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国人工电子耳市场：年龄组估计及趋势分析

  • 2023年及2030年按年龄族群分類的市场占有率
  • 细分仪表板
  • 按年龄分類的美国人工电子耳市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 成人
  • 孩子

第五章美国人工电子耳市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 美国人工电子耳市场依应用前景
  • 2018-2030年市场规模、预测及趋势分析
  • 医院
  • 诊所
  • 其他的

第六章美国人工电子耳市场：区域估算及趋势分析

  • 2023 年和 2030 年按地区分類的市场占有率份额
  • 美国人工电子耳市场按地区展望
  • 2018-2030年市场规模、预测及趋势分析
  • 西
  • 中西部
  • 东北
  • 西南
  • 东南

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • Cochlear Ltd
    • MED-EL Medical Electronics
    • Oticon Medical
    • Advanced Bionics Corporation
    • Sonova Holding AG
    • Medtronic
    • Nurotron Biotechnology Co., Ltd
    • ZPower, LLC
    • Widex A/S
Product Code: GVR-4-68040-281-5

U.S. Cochlear Implants Market Growth & Trends:

The U.S. cochlear implants market size is anticipated to reach USD 940.1 million by 2030, growing at CAGR of 6.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. The number of individuals with hearing impairments and the increasing prevalence of age-related hearing loss in the U.S. is driving the demand for cochlear implants in the U.S. market.

According to the National Institute of Deafness and Other Communication Disorders (NIDCD), 2 to 3 out of every 1000 children have hearing loss that can be identified in the U.S. It also stated that roughly 1 in 1000 live infants are affected by sensorineural unilateral hearing loss in the country. The U.S. Food and Drug Administration (FDA) authorized cochlear implantation in 2019 for children with single-sided deafness (SSD) who were five years or older to help these patients.

By raising awareness about hearing loss and the benefits of cochlear implants, these organizations increase demand and promote a better understanding of the technology, which would drive the market's growth. Government initiatives focusing on therapeutic value and discriminatory issues spurred by people with impairments, such as expanded coverage for cochlear implants in the U.S. promote market expansion.

U.S. Cochlear Implants Market Report Highlights:

  • Based on age group, the adult segment held the largest market share of over 64.2% in 2023 owing to the rising prevalence of hearing loss. The pediatric segment is expected to grow at the fastest CAGR from 2024 to 2030
  • Based on end-use, the clinics segment accounted for the largest revenue share in 2023. Clinics, particularly ENT clinics, are essential providers of cochlear implant services, offering expertise in evaluating candidates for implants, conducting surgeries, and providing post-operative care
  • The rising diagnosis rates, growing awareness of hearing impairment, growing desire for bilateral fittings, and supportive government programs are some factors expected to drive this growth.
  • In June 2021, Oticon Medical announced that the Neuro System, the company's product for treating individuals 18 years of age or older with bilateral severe-to-profound sensorineural hearing loss, has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). These individuals stand to benefit limitedly from wearable technology, by entering the U.S. market with its cochlear implant products.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Age Group
    • 1.2.2. End-use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Age Group outlook
    • 2.2.2. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Cochlear Implants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Cochlear Implants Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Cochlear Implants Market: Age Group Estimates & Trend Analysis

  • 4.1. Age Group Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Cochlear Implants Market by Age Group Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Adult
    • 4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6. Pediatric
    • 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)
    • 4.6.2. Adult Unilateral Implants
      • 4.6.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.6.3. Adult Bilateral Implants
      • 4.6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)
    • 4.6.4. Pediatric Unilateral Implants
      • 4.6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.6.5. Pediatric Bilateral Implants
      • 4.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)

Chapter 5. U.S. Cochlear Implants Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Cochlear Implants Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.2. Clinics
      • 5.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. U.S. Cochlear Implants Market: Region Estimates & Trend Analysis

  • 6.1. Regional Market Share, 2023 & 2030
  • 6.2. U.S. Cochlear Implants Market by Region Outlook
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 6.3.1. West
      • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.3.2. Midwest
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Northeast
      • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.4. Southwest
      • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.5. Southeast
      • 6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company heat map analysis, 2023
  • 7.4. Company Profiles
    • 7.4.1. Cochlear Ltd
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. MED-EL Medical Electronics
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Oticon Medical
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Advanced Bionics Corporation
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Sonova Holding AG
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Medtronic
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Nurotron Biotechnology Co., Ltd
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. ZPower, LLC
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Widex A/S
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of Secondary Sources
  • Table 3 U.S. Cochlear Implants Market, By Age group, 2018 - 2030 (USD Million)
  • Table 4 U.S. Cochlear Implants Market, By End-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Cochlear Implants Market, By Region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. Cochlear Implants market: market outlook
  • Fig. 9 U.S. Cochlear Implants competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. cochlear implants market driver impact
  • Fig. 14 U.S. cochlear implants market restraint impact
  • Fig. 15 U.S. cochlear implants market: Age Group movement analysis
  • Fig. 16 U.S. cochlear implants market: Age Group outlook and key takeaways
  • Fig. 17 Adult market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Pediatric market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Adult unilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Adult bilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Pediatric unilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Pediatric bilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. cochlear implants market: End-use movement analysis
  • Fig. 24 U.S. cochlear implants market: End-use outlook and key takeaways
  • Fig. 25 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. cochlear implants market: regional movement analysis
  • Fig. 29 U.S. cochlear implants market: regional outlook and key takeaways
  • Fig. 30 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)